Short Communication Open Access

Cancer Biomarkers: Emerging Tools for Early Detection, Prognosis, and Precision Oncology

Abstract

Cancer remains one of the leading causes of mortality worldwide, largely due to late-stage diagnosis, tumor heterogeneity, and therapeutic resistance. Cancer biomarkers have emerged as indispensable tools in modern oncology, enabling early detection, prognosis prediction, treatment selection, and monitoring of disease progression. These biomarkers include genetic, epigenetic, proteomic, and metabolic indicators that reflect underlying tumor biology. With advances in high-throughput sequencing, liquid biopsy, and computational biology, the role of biomarkers has expanded significantly in precision oncology. This short communication highlights the major categories of cancer biomarkers, their clinical applications, emerging technologies, and current challenges in translation from bench to bedside. The integration of multi-omics biomarkers with artificial intelligence is expected to redefine cancer diagnosis and personalized treatment strategies in the coming decade.

Elena Rodriguez-Klein

To read the full article Download Full Article | Visit Full Article